These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19715980)

  • 1. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin.
    Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F
    Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient.
    Weis F; Beiras-Fernandez A; Kaczmarek I; Sodian R; Vicol C; Reichart B; Weis M
    Ann Thorac Surg; 2007 Jul; 84(1):269-70. PubMed ID: 17588430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.
    Forrest GN; Donovan BJ; Lamp KC; Friedrich LV
    Ann Pharmacother; 2008 Feb; 42(2):213-7. PubMed ID: 18212253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin in the treatment of bacteremia.
    Sakoulas G; Golan Y; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of healthcare-associated infections in a pediatric population with an extracorporeal ventricular assist device.
    Fragasso T; Ricci Z; Grutter G; Albanese S; Varano C; Amodeo A; Cogo P
    Artif Organs; 2011 Nov; 35(11):1110-4. PubMed ID: 22097984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
    Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
    Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Segreti JA; Crank CW; Finney MS
    Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
    Levine DP; Lamp KC
    Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
    Carpenter CF; Chambers HF
    Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.